August 24, 2020
A Virginia federal judge granted class certification Friday to Zetia direct buyers accusing Merck and Glenmark Pharmaceuticals of conspiring to keep a generic version of the cholesterol drug off the market, rejecting attacks on the small size of the class and the companies representing them.
August 17, 2020
A federal magistrate judge has recommended that a group of Zetia buyers be granted class certification in a dispute accusing Merck and Glenmark Pharmaceuticals of conspiring to keep a generic version of the cholesterol drug off the market.
July 07, 2020
Merck and Glenmark Pharmaceuticals are trying to convince a Virginia federal court to smack down a magistrate's recommendation to certify a class of direct purchasers who have accused the duo of conspiring to keep a generic version of the cholesterol drug Zetia off the market.
May 06, 2020
A proposed class of drug buyers is coming out swinging after the second of two "desperate efforts" to unseat its lead plaintiff in a suit accusing Merck and Glenmark Pharmaceuticals of teaming up to keep a generic version of the cholesterol drug Zetia off the market.
March 09, 2020
A Virginia federal judge has given the final greenlight to a settlement that knocks Par Pharmaceutical out of a massive suit accusing Merck and Glenmark of plotting to hold off generic versions of Zetia and inflating the cholesterol drug's costs.
December 23, 2019
Drug wholesalers and retailers alleging Merck, Glenmark and Par Pharmaceuticals were part of a conspiracy to keep generic versions of cholesterol drug Zetia off the market can't sue Merck and Glenmark for overcharges they purportedly paid for Glenmark's generic, a Virginia federal judge ruled.
November 19, 2019
Direct drug buyers accusing Merck and Glenmark of conspiring to keep a generic version of the cholesterol drug Zetia off the market have urged a Virginia federal judge to certify their class, saying the alleged conspiracy forced the class members to pay higher prices.
October 30, 2019
A Virginia federal judge was wrong to recommend that drugmakers Merck and Glenmark be cleared of allegations that they were part of a three-way conspiracy to keep a generic version of the cholesterol drug Zetia off the market, direct drug buyers said Tuesday.
October 29, 2019
Kroger, Walgreens and a host of other retailers urged a Virginia federal judge Tuesday not to take up a magistrate's recommendation to clear Merck and Glenmark of allegations that they were part of a three-way conspiracy to keep a generic version of the cholesterol drug Zetia off the market.
October 16, 2019
A group of direct purchaser plaintiffs may find it harder to prove a pay-for-delay scheme over a generic version of Merck's Zetia after a Virginia federal judge recommended Tuesday that the drugmaker and generics company Glenmark be cleared of allegations of a three-way conspiracy with Glenmark's distributor, Par Pharmaceuticals.